As of 2026-09-29, the Fair Value of Microbix Biosystems Inc (MBX.TO) is -1.04 CAD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.30 CAD, the upside of Microbix Biosystems Inc is -453.24%.
With the market price of 0.30 CAD and our fair value calculation, Microbix Biosystems Inc (MBX.TO) is not a good investment. Investing in MBX.TO stocks now will result in a potential loss of 453.24%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | 5Y Avg | |
| Net income | 3.23 | 1.79 | -0.04 | 3.52 | -2.25 | 1.25 |
| YoY growth | 151.85% | -44.58% | -102.23% | 8,900.45% | -163.80% | 1,748.34% |
| Market Cap (mil) | 40.49 |
| P/E | |
| Forward P/E |
| EPS | -0.04 |
| Avg earnings growth rate | 1,748.34% |
| TTM earnings | -5.72 |